Why Relax Alcohol Advertising While Tightening E-Cigarette Rules? UK Vape Retailer VPZ Calls Out PM’s “Double Standards”

Jul.07.2025
Why Relax Alcohol Advertising While Tightening E-Cigarette Rules? UK Vape Retailer VPZ Calls Out PM’s “Double Standards”
UK e-cigarette retailer VPZ has written to the Prime Minister, criticizing the government for easing restrictions on alcohol advertising while tightening e-cigarette regulations. The company called the move a clear “double standard” that sends confusing public health messages.

Key Points:

 

·Policy controversy: The UK government's decision to lift restrictions on alcohol advertising and focus on labeling regulations has sparked dissatisfaction within the e-cigarette industry. 

 

·A comparison of industries shows that alcohol advertising privileges are retained while e-cigarette regulations continue to tighten. 

 

·VPZ has written to Prime Minister Sir Keir Starmer accusing the government of double standards.

 

·Harm reduction stance: VPZ emphasizes the e-cigarette industry's zero death record and urges the government to recognize its role in reducing smoking harms.

 

·Next steps: VPZ is demanding an explanation for the regulatory differences and seeking dialogue to push for sensible e-cigarette policies. 

 

·Social reactions: Health groups criticize the loosening of alcohol policies while industry supports labeling reforms. 

 


According to a report from Vape Business on July 4th, VPZ strongly condemned Prime Minister Sir Keir Starmer's decision following the government's move to lift proposed restrictions on alcohol advertising.

 

In a public letter sent on July 4, VPZ Operations Director Jamie Strachan expressed his "deep disappointment" with the company's stated public health policies.

 

Previously, the UK government released the "England Ten-Year Health Plan: Towards the Future," confirming that plans to restrict alcohol advertising have been put on hold in favor of implementing new labeling standards. This policy shift is reported to have been influenced by strong opposition from the alcohol industry and concerns that a ban could jeopardize trade relations between the UK and the US.

 

In the letter, VPZ criticized the government's public health regulatory approach, pointing out disparities in the treatment of the alcohol and e-cigarette industries.

 

"In the UK, over 10,000 people die each year from alcohol-related diseases. Despite this, the alcohol industry still enjoys widespread and significant advertising privileges."

 

Stratkan wrote.

 

On the other hand, Strakan pointed out that although the e-cigarette industry has gained recognition from the UK Department of Public Health and the National Health Service as a safer alternative to smoking, it faces "increasing regulation, scrutiny, and public information that we believe are both disproportionate and misleading.

 

The letter stated:

 

"So far, there have been no confirmed deaths caused by e-cigarette products. VPZ consistently upholds the highest compliance and responsibility standards, dedicated to helping adult smokers improve their health."

 

Stratkan is calling on the Prime Minister to provide a "clear explanation" as to why his government chose to lift restrictions on alcohol advertising while continuing to tighten regulations on e-cigarettes. He warns that this approach "will undermine harm reduction strategies and could potentially worsen public health.

 

The government has decided to cancel proposed restrictions on alcohol advertising, a move that has drawn criticism from health advocates but is welcomed by industry insiders. It is expected that ministers will now focus on stricter labeling regulations, including following Ireland's example of printing warnings about the potential carcinogenic effects of alcohol beverages.

 

Cover image source: Franchise Info

 

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
Oral Thin-Film Technology Firm CTT Pharma Eyes U.S. Nicotine Product Trials
CTT Pharmaceutical Holdings said it has signed a letter of intent with a U.S. company to conduct clinical trials and testing for several potential nicotine products using its patented oral thin-film technology.
Jun.18
UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
UK Councils Seize More Than 1.3 Million Non-Compliant Vapes One Year After Disposable Ban
One year after the UK disposable vape ban came into force, local authorities continue to seize illegal and non-compliant vaping products. FOI data compiled by nicotine retailer Northerner shows more than 1.3 million products were seized between June 2025 and May 2026, with Bolton recording the highest number of seizures and Swansea reporting the highest estimated value.
Jul.21
JT Plans ¥800 Billion Investment in Heated Tobacco Over Three Years, Betting on Ploom as Second Growth Engine
JT Plans ¥800 Billion Investment in Heated Tobacco Over Three Years, Betting on Ploom as Second Growth Engine
Japan Tobacco Inc. (JT) CEO Takehiko Tsutsui said the company plans to invest about ¥800 billion (approximately US$5.4 billion) in heated tobacco products over three years through 2028, aiming to establish Ploom as a second growth engine after combustible cigarettes. Tsutsui said Ploom AURA helped JT increase its share of Japan’s heated tobacco market to 15.8% in the first quarter of 2026. Ploom products are now available in 29 markets, with Ploom AURA sold in 25 markets including Japan. JT also plans to continue its cigarette business while positioning its food operations, particularly frozen noodle products in North America, as another growth opportunity.
Jul.23
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
Vape Industry Group Loses Alabama Court Fight as State Tightens Rules on Imported Products
The Alabama Supreme Court affirmed a lower court’s refusal to issue a preliminary injunction blocking the state’s 2025 electronic nicotine delivery systems law, allowing rules requiring covered products to be U.S.-made or FDA-authorized to remain in effect.
Jul.10
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
French Vape Market Under Pressure as Europe’s First Listed Vape Company Kumulus Vape Reports 7.8% H1 Revenue Decline, Retail Sales Rise 41.5%
Kumulus Vape, Europe’s first publicly listed vape company, reported a 7.8% year-on-year decline in first-half 2026 revenue. Amid changing conditions in France’s vape market, the company said channel diversification helped offset pressure, with physical store sales increasing 41.5% year on year. Listed on Euronext Access Paris in 2019 and later transferred to Euronext Growth Paris, Kumulus Vape is viewed as a representative company of Europe’s vape sector. Its performance highlights the industry’s shift from rapid expansion toward more operationally focused growth.
Jul.27
PMI Highlights 43 Million Smoke-Free Users at Stockholm Summit
PMI Highlights 43 Million Smoke-Free Users at Stockholm Summit
Philip Morris International says about 43 million adults worldwide now use its smoke-free products, with nearly 70% having stopped using cigarettes and smoke-free products accounting for about 43% of its net revenues.
Jun.18